Non-bioequivalence of sublingual nifedipine.
作者信息
Rietbrock N, Kausch M, Engelhardt M, Woodcock B G
出版信息
Br J Clin Pharmacol. 1987 May;23(5):589-90. doi: 10.1111/j.1365-2125.1987.tb03096.x.
Abstract
摘要
相似文献
1
Non-bioequivalence of sublingual nifedipine.舌下含服硝苯地平的非生物等效性。
Br J Clin Pharmacol. 1987 May;23(5):589-90. doi: 10.1111/j.1365-2125.1987.tb03096.x.
2
Kinetics and dynamics of nifedipine after oral and sublingual doses.口服和舌下给药后硝苯地平的动力学与动力学过程
Am J Med. 1986 Dec 15;81(6A):2-5. doi: 10.1016/0002-9343(86)90787-4.
3
[Bioavailability of new nifedipine preparations in man. 2. Bioequivalence of nifedipine in the form of soft gelatin capsules].[新型硝苯地平制剂在人体中的生物利用度。2. 软胶囊形式硝苯地平的生物等效性]
Arzneimittelforschung. 1985;35(12):1842-4.
4
Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.两种市售硝苯地平口服制剂的药代动力学和药效学
Int J Clin Pharmacol Ther Toxicol. 1991 Sep;29(9):337-41.
5
Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.单次给药和重复给药后口服硝苯地平制剂与缓释参比制剂的生物等效性研究
Arzneimittelforschung. 1995 Dec;45(12):1266-70.
6
Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.健康志愿者口服尼群地平后的生物等效性与代谢
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S968-73.
7
[The bioequivalence of two nifedipine fluid capsules].[两种硝苯地平软胶囊的生物等效性]
Arzneimittelforschung. 1989 Dec;39(12):1597-9.
8
[Treatment of hypertensive emergencies with sublingual nifedipine].舌下含服硝苯地平治疗高血压急症
Minerva Cardioangiol. 1986 Oct;34(10):619-24.
9
[A model study of bioequivalence of dissolved nifedipine from soft gelatin capsules].[软胶囊中硝苯地平溶出度生物等效性的模型研究]
Arzneimittelforschung. 1988 Feb;38(2):300-4.
10
Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.硝苯地平在健康志愿者中不同给药途径的生物利用度和药代动力学。
Arch Invest Med (Mex). 1989 Apr-Jun;20(2):129-35.
引用本文的文献
1
Generic drugs. Therapeutic equivalence.仿制药。治疗等效性。
Drug Saf. 1996 Oct;15(4):233-42. doi: 10.2165/00002018-199615040-00001.
2
Factors affecting the absolute bioavailability of nifedipine.影响硝苯地平绝对生物利用度的因素。
Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.
本文引用的文献
1
Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection.采用气液色谱法和电子捕获检测法测定血浆中的硝苯地平。
Clin Chem. 1983 Jan;29(1):158-60.
2
Nifedipine in hypertensive emergencies.硝苯地平用于高血压急症。
Br Med J (Clin Res Ed). 1983 Feb 19;286(6365):648-9. doi: 10.1136/bmj.286.6365.648-c.
3
Nifedipine serum concentrations following sublingual and oral doses.舌下给药和口服给药后的硝苯地平血清浓度。
Int J Clin Pharmacol Ther Toxicol. 1986 Jun;24(6):283-6.
4
Ineffectiveness of sublingual nitroglycerin in patients with dry mucous membranes.舌下含服硝酸甘油对黏膜干燥患者无效。
N Engl J Med. 1986 Jan 16;314(3):181. doi: 10.1056/NEJM198601163140313.
Zotero 插件